BioCentury | Mar 26, 2020
Product Development

COVID-19 roundup: Grifols partners with BARDA, FDA on convalescent plasma; plus Vir, Sorrento, Ascletis, BMS and Ipsen

...for COVID-19 mAbs. Financial terms were undisclosed. Sorrento’s COVID-19 vaccine Sorrento Therapeutics Inc. (NASDAQ:SRNE) unveiled STI-6991...
...need to obtain accelerated approval. The company aims to have STI-6991 in clinical trials mid-year. STI-6991...
...ITMN B) Grifols S.A. Vir Biotechnology Inc. Xencor Inc. Ascletis Pharma Inc. Sorrento Therapeutics Inc. Bristol Myers Squibb Co. Ipsen Group Coronavirus S protein STI-6991 COVID-19 cov19count SARS-CoV-2 convalescent...
Items per page:
1 - 1 of 1